Category:Antibody-Drug Conjugates and other protein-drug conjugates: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

31 March 2024

24 March 2024

  • curprev 04:5504:55, 24 March 2024‎ Lazy talk contribs‎ 1,816 bytes +1,816‎ Created page with "== Introduction == Antibody-Drug Conjugates (ADCs) and other protein-drug conjugates represent a novel class of therapeutic agents in cancer treatment. These sophisticated therapies combine the specificity of antibodies or other proteins, which target specific markers on cancer cells, with potent cytotoxic drugs. This selective approach aims to minimize damage to healthy tissues while delivering powerful cancer-fighting agents directly to tumor cells. ADCs and similar c..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Category:Antibody-Drug_Conjugates_and_other_protein-drug_conjugates"